Drug addiction

This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker)
December 15, 2019 - 9:06 pm
The gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said. Some conference attendees were stunned when they saw the company logo: Mundipharma, the...
Read More
In this Thursday, Oct. 31, 2019, photo, a recovering tramadol addict waits for her medication at a de-addiction center in Kapurthala, in the northern Indian state of Punjab. The pills were everywhere, as legitimate medication sold in pharmacies, but also illicit counterfeits hawked by itinerant peddlers and street vendors. India has twice the global average of illicit opiate consumption. Researchers estimate about 4 million Indians use heroin or other opioids, and a quarter of them live in the Punjab, India's agricultural heartland bordering Pakistan. (AP Photo/Channi Anand)
December 13, 2019 - 9:53 am
KAPURTHALA, India (AP) — Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists. These pills, the world has been told, are safer than the OxyContins, the Vicodins, the fentanyls that have wreaked so much...
Read More
FILE - In this Tuesday, June 11, 2019, file photo, marijuana equipment sits on display along a window at the Minerva medical cannabis dispensary in Santa Fe, N.M. The U.S. government is explicitly barring federal dollars for opioid addiction treatment from being used on medical marijuana. (AP Photo/Morgan Lee, File)
November 22, 2019 - 10:42 am
The U.S. government is barring federal dollars meant for opioid addiction treatment to be used on medical marijuana. The move is aimed at states that allow marijuana for medical uses, particularly those letting patients with opioid addiction use pot as a treatment, said Dr. Elinore McCance-Katz,...
Read More
FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
October 06, 2019 - 2:50 pm
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
CORRECTS STATE TO OHIO NOT PENNSYLVANIA - Narcotics detective Ben Hill, with the Barberton Police Department, shows two bags of medications that are are stored in their headquarters and slated for destruction, Wednesday, Sept. 11, 2019, in Barberton, Ohio. Attorneys representing some 2,000 local governments said Wednesday they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis. (AP Photo/Keith Srakocic)
September 11, 2019 - 6:51 pm
HARTFORD, Conn. (AP) — A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation's opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue against the company and...
Read More
September 05, 2019 - 1:44 pm
ROME (AP) — Italian authorities on Thursday suspended a doctor and three pharmacists in an investigation of the suspected fraudulent prescription of oxycodone, a potentially addictive painkiller. In allegations that appear to have similarities to the U.S. opioid addiction epidemic, a physician in...
Read More
FILE - In this Friday, Aug. 17, 2018, file photo, Christine Gagnon of Southington, Conn., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday, Sept. 7, 2019, in a message to their counterparts across the country. (AP Photo/Jessica Hill, File)
August 30, 2019 - 9:50 pm
HARTFORD, Conn. (AP) — An offer from OxyContin maker Purdue Pharma and the Sackler family to settle some 2,000 lawsuits over their contribution to the national opioid crisis is receiving growing pushback from state and local officials who say the proposed deal doesn't include enough money or...
Read More
Judge Thad Balkman announces his decision in the Opioid Lawsuit In Norman, Okla., Monday, Aug. 26, 2019. Balkman found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis and ordered the consumer products giant to pay $572 million to help abate the problem in the coming years. (AP Photo/Sue Ogrocki, Pool)
August 27, 2019 - 6:01 pm
OKLAHOMA CITY (AP) — Oklahoma's legal fight against the opioid industry has racked up settlements and judgments of nearly $1 billion, but as the numbers keep rising, so do concerns over how that money will be spent. Experts say the $572 million judgment issued Monday against consumer products giant...
Read More
Protesters, including Carol Lorento, center, gather outside a courthouse on Friday, Aug. 2, 2019, in Boston, where a judge was to hear arguments in Massachusetts' lawsuit against Purdue Pharma over its role in the national drug epidemic. Organizers said they wanted to continue to put pressure on the Connecticut pharmaceutical company and the Sackler family that owns it. (AP Photo/Charles Krupa)
August 02, 2019 - 9:47 am
BOSTON (AP) — Parents who lost children to fatal overdoses and other addiction recovery activists are rallying outside a Boston courthouse Friday as a judge hears arguments in Massachusetts' lawsuit against Purdue Pharma over its role in the national drug epidemic. About 100 protesters gathered in...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 11:32 am
WASHINGTON (AP) — Dr. Raeford Brown was uniquely positioned to help the U.S. government answer a critical question: Is a new version of the painkiller OxyContin helping fight the national opioid epidemic? An expert in pain treatment at the University of Kentucky, Brown led a panel of outside...
Read More

Pages